Search clinical trials for: capecitabine RTD

Total 4618 results

AllVascular

Recruiting

Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer (SYS-CAPLIOX)

Liver Metastasis Colon Cancer

Australia
Translational Genomics Research Institute
Eli Lilly and Company

Withdrawn

Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

Metastatic Colorectal Cancer

United States
Universitair Ziekenhuis Brussel
Vrije Universiteit Brussel

Completed

Simultaneous Integrated Boost Preoperative Radiotherapy for Rectum Cancer (RectumSIB)

Rectal Cancer

Belgium
Samsung Medical Center

Unknown

XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy

Biliary Tract Cancer

Korea, Republic of
Fudan University

Unknown

Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients

Colorectal Cancer

China
AGC Biologics S.p.A.

Completed

NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer

Colon Cancer

Italy
University of Medicine and Dentistry of New Jersey
Bristol-Myers Squibb; Rutgers Cancer Institute of New Jersey

Terminated

First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

Colorectal Cancer

United States
University of Virginia
National Cancer Institute (NCI)

Completed

Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Head and Neck Cancer

United States
Aronex Pharmaceuticals

Unknown

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Colorectal Neoplasms
Akamis Bio

Not yet recruiting

NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer (FORTRESS)

Locally Advanced Rectal Cancer (LARC)
Universidad de León

Recruiting

Analysis of the Effectiveness of Neoadjuvant Chemotherapy in the Treatment of Colon Cancer Locally Advanced (ELECLA) (ELECLA)

Locally Advanced Colon Cancer

Spain
Cancer Institute and Hospital, Chinese Academy...

Unknown

Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer

Triple-negative Breast Cancer

China
LiNing

Not yet recruiting

A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer

Stomach Neoplasms

China
National Cancer Center, Korea
Korean Cancer Study Group

Unknown

Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer (PREPARE)

Adenocarcinoma | Rectal Neoplasms

Korea, Republic of
Croatian Cooperative Group for Clinical Research...
Roche Pharma AG

Unknown

Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer

Breast Cancer | Metastasis

Croatia
Asan Medical Center
Seoul National University Bundang Hospital; Severance Hospital; Hallym University... and other collaborators

Recruiting

Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH

Gastric Cancer, Adjuvant Chemotherapy, XO

Korea, Republic of
Peking University
Xiansheng Pharmaceutical Company

Completed

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

Advanced Gastric Cancer

China
South Eastern European Research Oncology Group
Roche Pharma AG

Unknown

Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer

Breast Cancer | Metastasis

Croatia
Second Affiliated Hospital, School of Medicine,...

Recruiting

Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer

Colorectal Cancer

China
Peking University Cancer Hospital & Institute
Peking University People's Hospital; Peking Union Medical College Hospital

Recruiting

Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) (EPAC1)

Adjuvant Chemotherapy

China
UNICANCER
Novartis

Completed

Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative (GEP14-LEECAP)

Breast Cancer

France
The Affiliated Hospital of Qingdao University

Completed

Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients With Colorectal or Breast Cancer

Patient Participation

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab

HER2 Positive Metastatic Breast Cancer

China
AstraZeneca

Completed

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

Pancreatic Cancer

United States, Bulgaria, Hungary, Romania, Australia
Royal Marsden NHS Foundation Trust

Completed

A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer

Rectal Cancer
National Cancer Center, Korea

Unknown

Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma

Pancreatic Cancer

Korea, Republic of
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer

Gastric Cancer

Greece
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline

Completed

Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer

Breast Cancer

United States
Hoffmann-La Roche

Terminated

A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.

Breast Cancer

Taiwan
National Cancer Institute (NCI)

Completed

GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer

Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer

United States
Assiut University

Not yet recruiting

Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy

Breast Cancer
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
Institute of Oncology Ljubljana

Unknown

Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer (XERT)

Rectal Cancer

Slovenia
Nanfang Hospital of Southern Medical University

Recruiting

Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Dutch Colorectal Cancer Group
Sanofi; Roche Pharma AG

Terminated

Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer

Colorectal Cancer | Liver Metastases

Netherlands
Norwegian Breast Cancer Group

Completed

Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC

Breast Neoplasm

Norway
Henan Cancer Hospital

Recruiting

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

Breast Cancer

China
Eisai Inc.

Completed

Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer

Thyroid Cancer

United States, France, Ukraine, Peru, Russian Federation, Argentina
University of California, San Francisco

Terminated

Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)

Cholangiocarcinoma | Klatskin Tumor | Biliary Tract Cancer

United States
National University Hospital, Singapore

Unknown

A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab

Rectal Cancer

Singapore
AstraZeneca

Completed

IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure

Colorectal Cancer

Spain
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma

Colorectal Cancer

France
Medicrea, USA Corp.

Withdrawn

Personalized Spine Study Group Registry

Degenerative Disc Disease | Spinal Stenosis | Spinal Fusion | Kyphoscoliosis | Scoliosis; Adolescence | Pseudoarthrosis of Spine | Kyphoses, Scheuermann
NCIC Clinical Trials Group

Terminated

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

Canada
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction

Gastric Cancer | Esophageal Cancer

United States
Hoffmann-La Roche

Completed

XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer

Breast Cancer

Hungary
Indiana University School of Medicine
Aventis Pharmaceuticals

Completed

Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer

Breast Cancer

United States
Cancer Research UK

Completed

Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

Colorectal Cancer

United Kingdom
Roswell Park Cancer Institute

Completed

Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum

Colorectal Cancer

United States

3

Subscribe